Bringing the fundamentals into focus…
Back to Century Therapeutics, Inc.
How Century Therapeutics, Inc. stacks up
IPSC · against 339 other Healthcare companies of similar size
Profitability
15/ 100
Near the bottom of its peers.
Ranked #267 of 340 · scores higher than 21% of peers
Bars: peers in each 10-point band of the profitability score42 peers with a profitability score of 10–19, including IPSC · Click a bar to see the companies
Why profitability scores 15?
Weighted metrics compared with all Healthcare companies.Mainly because of its return on assets, operating margin and return on invested capital, which are weaker than most Healthcare peers.
- a lower return on assets: weaker than 90% of peers. Return on assets: -38.3% vs peer median 1.7%
- a thinner operating margin: weaker than 88% of peers. Operating margin: -107.2% vs peer median 7.1%
- a lower return on invested capital: weaker than 88% of peers. Return on invested capital: -50.6% vs peer median 4.7%
Metric by metric
Position: dot = IPSC, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | IPSC | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 302 reported | -50.6% | -0.2% | 16% | 33% | |
| Operating marginHigher is better · 317 reported | -107.2% | 2.5% | 18% | 33% | |
| Return on assetsHigher is better · 340 reported | -38.3% | -0.4% | 13% | 33% | |
| Return on equityHigher is better · 319 reported | -49.7% | -0.7% | 18% | Context only | |
| Gross marginHigher is better · 356 reported | 0.0% | 37.1% | 5% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around IPSC| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 433M USD | 99 | 81 | |
| 2 | 5.5B NOK (≈$523M) | 98 | 71 | |
| 2 | 261M USD | 98 | 97 | |
| 4 | 1.4B HKD (≈$181M) | 97 | 61 | |
| 4 | 356M AUD (≈$235M) | 97 | 81 | |
| 257 | 142M USD | 17 | 45 | |
| 265 | 3.5B HKD (≈$451M) | 16 | 51 | |
| 265 | 302M USD | 16 | 17 | |
| 267 | 296M USD | 15 | 26 | |
| 267 | 275M USD | 15 | 46 | |
| 267 | 424M USD | 15 | 45 | |
| 267 | 139M USD | 15 | 32 | |
| 271 | 11.6B TWD (≈$360M) | 14 | 45 | |
| 271 | 186M USD | 14 | 43 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score